← Leaderboards
Pamela B Davis
Case Western Reserve University
$114,848,546
Attributed
$116,949,341
Total exposure
46
Grants
36
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $27.3M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$182,454,502 · 50
By mechanism
UL1$136,733,148 · 27
KL2$16,222,590 · 2
P30$8,252,282 · 4
R01$6,935,803 · 5
P50$4,455,544 · 2
TL1$3,719,390 · 2
Top collaborators
- Rong Xu5 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Margaret P Chandler$2,153,283
- Zhiyong Lin$10,853,493
- Arthur J McCullough$9,778,555
- Robert Tracy Ballock$2,790,934
- Charles Leslie Hoppel$9,267,801
Others in their field
Top investigators on “Universities”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$507,483,583
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$463,124,587
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
UniversitiesClinicResearch InfrastructureBaseCystic FibrosisClinical TrialsClinical ResearchCommunitiesInflammationMedical CenterProgramsInstitutionDesignPhysician Scientist Award (Program)CitiesMultidisciplinaryResourcesHome EnvironmentTranslationsCollaborationsBiomedical ResearchLaboratory MouseTraining ProgramsGrant
Grant awards (111)
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments$772,838
R01 · FY2025 · AG
Medical Student Summer Research Program in Aging and Alzheimer's disease (MSSRPA)$91,055
T35 · FY2024 · AG · contact PI
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients$362,250
R01 · FY2023 · AA
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments$2,342,002
RF1 · FY2022 · AG
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients$362,250
R01 · FY2022 · AA
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients$362,250
R01 · FY2021 · AA
Clinical and Translational Science Collaborative of Cleveland$10,156,543
UL1 · FY2014 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$2,230,012
KL2 · FY2014 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$559,791
TL1 · FY2014 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$118,850
UL1 · FY2014 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$9,545,141
UL1 · FY2013 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$2,179,352
KL2 · FY2013 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$554,516
TL1 · FY2013 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$10,475,754
UL1 · FY2012 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$2,285,193
KL2 · FY2012 · TR · contact PI
Clinical and Translational Science Collaborative of Cleveland$554,516
TL1 · FY2012 · TR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$10,564,692
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$4,199,050
UL1 · FY2011 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA$2,332,769
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,699,609
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,699,608
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,399,684
UL1 · FY2011 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (TL1)$530,024
TL1 · FY2011 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$468,735
UL1 · FY2011 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (KL2)$447,907
KL2 · FY2011 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$297,293
UL1 · FY2011 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$10,701,712
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$4,280,685
UL1 · FY2010 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (KL2)$2,287,966
KL2 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,140,342
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,605,257
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,605,257
UL1 · FY2010 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA$1,070,171
UL1 · FY2010 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (TL1)$525,034
TL1 · FY2010 · RR · contact PI
Nucleolin-mediated cell entry of DNA nanoparticles$235,500
R21 · FY2010 · DK · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$10,717,300
UL1 · FY2009 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA$3,365,446
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,884,776
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,403,998
UL1 · FY2009 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (KL2)$2,270,647
KL2 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,031,540
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,031,540
UL1 · FY2009 · RR · contact PI
Case Western Researve Clinical and Translational Science Institute (UL1)$978,776
UL1 · FY2009 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (TL1)$522,611
TL1 · FY2009 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$491,982
UL1 · FY2009 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA (UL1): BPCA$491,982
UL1 · FY2009 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$478,039
UL1 · FY2009 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA (UL1): BPCA$478,039
UL1 · FY2009 · RR · contact PI
Nucleolin-mediated cell entry of DNA nanoparticles$196,250
R21 · FY2009 · DK · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$10,719,513
UL1 · FY2008 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA$4,200,441
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,150,358
UL1 · FY2008 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (KL2)$2,465,583
KL2 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,100,274
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,268,440
UL1 · FY2008 · RR · contact PI
Limiting Inflammation in the CF Lung$508,294
R01 · FY2008 · HL · contact PI
Accessing the Airway for Cystic Fibrosis Gene Therapy$334,100
R01 · FY2008 · DK · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (TL1)$331,028
TL1 · FY2008 · RR · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (UL1)$8,289,776
UL1 · FY2007 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA$4,144,888
UL1 · FY2007 · RR · contact PI
Case Western Reserve University/ Cleveland Clinic CTSA$2,055,930
KL2 · FY2007 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA FOR PEDIATRIC RESEARCH$1,657,955
UL1 · FY2007 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA FOR CLINICAL TRIALS$1,657,955
UL1 · FY2007 · RR · contact PI
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA FOR AIDS RESEARCH$828,978
UL1 · FY2007 · RR · contact PI
Limiting Inflammation in the CF Lung$362,679
R01 · FY2007 · HL · contact PI
Accessing the Airway for Cystic Fibrosis Gene Therapy$340,918
R01 · FY2007 · DK · contact PI
Administrative Core$215,483
P30 · FY2007 · DK · contact PI
Limiting Inflammation in the CF Lung$145,100
R01 · FY2007 · HL · contact PI
Case Western Reserve University/Cleveland Clinic CTSA (TL1)$141,870
TL1 · FY2007 · RR · contact PI
General Clinical Research Center$1
M01 · FY2007 · RR · contact PI
CORE CENTER - CYSTIC FIBROSIS$1,113,075
P30 · FY2006 · DK · contact PI
RESEARCH TRAINING PROGRAM PLAN$504,690
T32 · FY2006 · HL · contact PI
Limiting Inflammation in the CF Lung$373,511
R01 · FY2006 · HL · contact PI
Accessing the Airway for Cystic Fibrosis Gene Therapy$351,100
R01 · FY2006 · DK · contact PI
CORE CENTER - CYSTIC FIBROSIS$1,147,500
P30 · FY2005 · DK
RESEARCH TRAINING PROGRAM PLAN$501,528
T32 · FY2005 · HL
Limiting Inflammation in the CF Lung$382,500
R01 · FY2005 · HL
Accessing the Airway for Cystic Fibrosis Gene Therapy$359,550
R01 · FY2005 · DK
POLYMERIC IMMUNOGLOBULIN RECEPTOR TARGETING OF AIRWAYS$225,777
R21 · FY2005 · DK
CORE CENTER - CYSTIC FIBROSIS$1,147,500
P30 · FY2004 · DK
Research Training Program Plan$497,318
T32 · FY2004 · HL
Accessing the Airway for Cystic Fibrosis Gene Therapy$359,550
R01 · FY2004 · DK
POLYMERIC IMMUNOGLOBULIN RECEPTOR TARGETING OF AIRWAYS$201,685
R21 · FY2004 · DK
CORE CENTER - CYSTIC FIBROSIS$1,146,175
P30 · FY2003 · DK
GENE THERAPY FOR CYSTIC FIBROSIS VIA THE SEC RECEPTOR$265,431
R01 · FY2003 · DK
RESEARCH TRAINING PROGRAM PLAN$37,867
T32 · FY2003 · HL
INFLAMMATION IN THE CF LUNG$1,286,376
P50 · FY2002 · HL
CORE CENTER - CYSTIC FIBROSIS$1,147,500
P30 · FY2002 · DK
GENE THERAPY FOR CYSTIC FIBROSIS VIA THE SEC RECEPTOR$265,431
R01 · FY2002 · DK
INFLAMMATORY RESPONSE TO PSEUDOMONAS IN CYSTIC FIBROSIS MICE AND CELLS$263,865
P50 · FY2002 · HL
RESEARCH TRAINING PROGRAM PLAN$1
T32 · FY2002 · HL
PILOT AND FEASIBILITY PROGRAM$0
P30 · FY2002 · DK
RESEARCH TRAINING PROGRAM$0
P30 · FY2002 · DK
INFLAMMATION IN THE CF LUNG$1,259,696
P50 · FY2001 · HL
CORE CENTER - CYSTIC FIBROSIS$1,191,169
P30 · FY2001 · DK
RESEARCH TRAINING PROGRAM PLAN$361,220
T32 · FY2001 · HL
IN VITRO EVALUATION OF APPROACHES TO GENE THERAPY FOR CYSTIC FIBROSIS$294,555
P41 · FY2001 · RR
LONGITUDINAL ASSESS: PULMONARY FUNCTION IN CYSTIC FIBROSIS:INFLAMMATORY RESPONSE$294,555
P41 · FY2001 · RR
GENE THERAPY FOR CYSTIC FIBROSIS VIA THE SEC RECEPTOR$265,431
R01 · FY2001 · DK
INFLAMMATORY RESPONSE TO PSEUDOMONAS IN CYSTIC FIBROSIS MICE AND CELLS$263,865
P50 · FY2001 · HL
TARGETING THE SEC RECEPTOR FOR GENE THERAPY$252,231
R01 · FY2001 · DK
PILOT AND FEASIBILITY PROGRAM$0
P30 · FY2001 · DK
RESEARCH TRAINING PROGRAM$0
P30 · FY2001 · DK
INFLAMMATION IN THE CF LUNG$1,214,471
P50 · FY2000 · HL
CORE CENTER--CYSTIC FIBROSIS$1,143,880
P30 · FY2000 · DK
RESEARCH TRAINING PROGRAM PLAN$344,233
T32 · FY2000 · HL
GENE THERAPY FOR CYSTIC FIBROSIS VIA THE SEC RECEPTOR$265,431
R01 · FY2000 · DK
TARGETING THE SEC RECEPTOR FOR GENE THERAPY$244,958
R01 · FY2000 · DK
INFLAMMATORY RESPONSE TO PSEUDOMONAS IN CYSTIC FIBROSIS MICE AND CELLS$167,271
P50 · FY2000 · HL
IN VITRO EVALUATION OF APPROACHES TO GENE THERAPY FOR CYSTIC FIBROSIS$3,754
P41 · FY2000 · RR
LONGITUDINAL ASSESS: PULMONARY FUNCTION IN CYSTIC FIBROSIS:INFLAMMATORY RESPONSE$3,754
P41 · FY2000 · RR